We are live on ! Find out more
GRTX

Galera Therapeutics, Inc. Common Stock
GRTX

Delisted

GRTX was delisted on the 3rd of June, 2024.

Back to rankings

47 hedge funds and large institutions have $26.9M invested in Galera Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more call options, than puts

Call options by funds: $1.79M | Put options by funds: $824K

33% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 9

7% more funds holding

Funds holding: 44 → 47 (+3)

33% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 12

47% less capital invested

Capital invested by funds: $50.6M → $26.9M (-$23.7M)

Holders
47
Holders Change
+3
Holders Change %
+6.82%
% of All Funds
0.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
8
Reduced
12
Closed
9
Calls
$1.79M
Puts
$824K
Net Calls
+$967K
Net Calls Change
-$2.02M

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$1.14M
2
Two Sigma Investments
Two Sigma Investments
New York
+$416K
3
BlackRock
BlackRock
New York
+$389K
4
Citadel Advisors
Citadel Advisors
Florida
+$361K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$348K

Top Sellers

Rank Fund Capital Flow
1
ACP
Acuta Capital Partners
California
-$1.21M
2
Morgan Stanley
Morgan Stanley
New York
-$482K
3
CS
Credit Suisse
Switzerland
-$450K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$439K
5
Millennium Management
Millennium Management
New York
-$255K
Name Holding Trade Value Shares
Change 		Change in
Stake
SI
1
Sofinnova Investments
California
$7.34M – – –
NHAS
2
Novo Holdings A/S
Denmark
$5.85M – – –
Blackstone Inc
3
Blackstone Inc
New York
$4M – – –
TCM
4
Tekla Capital Management
Massachusetts
$2.14M – – –
NFGH
5
Nan Fung Group Holdings
Hong Kong
$1.46M – – –
Renaissance Technologies
6
Renaissance Technologies
New York
$1.04M +$1.14M +439,134 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$1.04M -$82.1K -31,516 -7%
BlackRock
8
BlackRock
New York
$765K +$389K +149,253 +87%
Two Sigma Investments
9
Two Sigma Investments
New York
$380K +$416K +159,698 New
Two Sigma Advisers
10
Two Sigma Advisers
New York
$357K +$348K +133,700 +815%
BCM
11
Bridgeway Capital Management
Texas
$350K +$261K +100,000 +213%
Citadel Advisors
12
Citadel Advisors
Florida
$330K +$361K +138,584 New
Belvedere Trading
13
Belvedere Trading
Illinois
$207K +$12.8K +4,927 +5%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$188K +$11K +4,221 +6%
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$142K -$225K -86,314 -59%
Millennium Management
16
Millennium Management
New York
$135K -$255K -97,857 -63%
BC
17
BIT Capital
Germany
$119K +$130K +50,000 New
Ensign Peak Advisors
18
Ensign Peak Advisors
Utah
$95K – – –
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$90K +$98.2K +37,693 New
CM
20
Crestline Management
Texas
$83K +$90.5K +34,749 New
Group One Trading
21
Group One Trading
Illinois
$82K -$89.3K -34,292 -50%
OQS
22
Occudo Quantitative Strategies
Florida
$72K +$79.3K +30,442 New
State Street
23
State Street
Massachusetts
$68K +$7.55K +2,900 +11%
SSA
24
Schonfeld Strategic Advisors
New York
$63K +$69.3K +26,600 New
RJFSA
25
Raymond James Financial Services Advisors
Florida
$53K – – –
1
2 3

GRTX Hedge Fund Activity: Q1 2022 in Review

47 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Galera Therapeutics, Inc. Common Stock (GRTX) for Q1 2022, worth a combined $26.9M — down 47% from $50.6M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new GRTX positions and 9 closed out — a net gain of 3 holders — while 8 added to existing stakes and 12 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $1.14M. The largest seller was Acuta Capital Partners, exiting entirely with an estimated $1.21M sold.

  • 47 institutional investors held Galera Therapeutics, Inc. Common Stock (GRTX) as of Q1 2022, up from 44 in Q4 2021.
  • Funds reported $26.9M of Galera Therapeutics, Inc. Common Stock stock for Q1 2022, down 47% quarter-over-quarter.
  • 12 funds opened new Galera Therapeutics, Inc. Common Stock positions in Q1 2022 and 9 closed out, a net change of +3 holders.
  • The largest Galera Therapeutics, Inc. Common Stock buyer in Q1 2022 was Renaissance Technologies, an estimated $1.14M added.
  • The largest Galera Therapeutics, Inc. Common Stock seller in Q1 2022 was Acuta Capital Partners, an estimated $1.21M sold.

Based on aggregated 13F filings for Q1 2022.